186 related articles for article (PubMed ID: 23632603)
41. A case of purpura fulminans arising from cryptococcosis.
Inokuchi R; Nakamura K; Aoki Y; Hiruma T; Gunshin M; Matsubara T; Ishii T; Nakajima S; Yahagi N; Sato H; Shinohara K
Am J Respir Crit Care Med; 2012 Jul; 186(1):109-10. PubMed ID: 22753692
[No Abstract] [Full Text] [Related]
42. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R
Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571
[TBL] [Abstract][Full Text] [Related]
43. Micafungin for the prophylaxis and treatment of Candida infections.
Fritz JM; Brielmaier BD; Dubberke ER
Expert Rev Anti Infect Ther; 2008 Apr; 6(2):153-62. PubMed ID: 18380597
[TBL] [Abstract][Full Text] [Related]
44. Concurrence of two different opportunistic mycoses complicated by visceral dissemination diagnosed in "AIDS presenter" patients: candidiasis and cryptococcosis.
Manfredi R; Calza L
J Chemother; 2007 Jun; 19(3):350-1. PubMed ID: 17594935
[No Abstract] [Full Text] [Related]
45. Cryptococcosis: long-lasting presence of fungi after successful treatment.
Kobayashi M; Murata K; Hiroshi HO; Tokura Y
Acta Derm Venereol; 2004; 84(4):320-1. PubMed ID: 15339084
[No Abstract] [Full Text] [Related]
46. [Micafungin: new challenges, new possibilities in the treatment of invasive fungal infection].
Pemán J; Torre-Cisneros J
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():1-2. PubMed ID: 21420569
[No Abstract] [Full Text] [Related]
47. [Relationship between the effectiveness and dose of micafungin in the treatment of candidemia].
Sugawara T; Murakami N; Uetake N; Matsumoto S; Miyamori S; Okamoto R; Hiraki K
Yakugaku Zasshi; 2014; 134(3):433-8. PubMed ID: 24584025
[TBL] [Abstract][Full Text] [Related]
48. Disseminated cryptococcosis in a diabetic patient.
Poojary S; Khatu S
Cutis; 2014 Aug; 94(2):91-5. PubMed ID: 25184644
[TBL] [Abstract][Full Text] [Related]
49. [Therapy of candidemia and invasive candidiasis according to guidelines].
Glöckner A
Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
[TBL] [Abstract][Full Text] [Related]
50. Economic evaluation of micafungin vs. liposomal amphotericin B (LAmB) for the treatment of candidaemia and invasive candidiasis (IC).
Neoh CF; Liew D; Slavin MA; Marriott D; Chen SC; Morrissey O; Stewart K; Kong DC
Mycoses; 2013 Sep; 56(5):532-42. PubMed ID: 23496163
[TBL] [Abstract][Full Text] [Related]
51. Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus).
Kido N; Makimura K; Kamegaya C; Shindo I; Shibata E; Omiya T; Yamamoto Y
Med Mycol; 2012 Apr; 50(3):291-8. PubMed ID: 21859391
[TBL] [Abstract][Full Text] [Related]
52. Micafungin as antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: results of different dosage levels in clinical practice.
Langebrake C; Rohde H; Lellek H; Wolschke C; Kröger NM
Clin Transplant; 2014 Mar; 28(3):286-91. PubMed ID: 24479680
[TBL] [Abstract][Full Text] [Related]
53. Wickerhamomyces anomalus fungal keratitis responds to topical treatment with antifungal micafungin.
Kamoshita M; Matsumoto Y; Nishimura K; Katono Y; Murata M; Ozawa Y; Shimmura S; Tsubota K
J Infect Chemother; 2015 Feb; 21(2):141-3. PubMed ID: 25239058
[TBL] [Abstract][Full Text] [Related]
54. Cryptococcus neoformans abscess and osteomyelitis in an immunocompetent patient with tuberculous lymphadenitis.
Al-Tawfiq JA; Ghandour J
Infection; 2007 Oct; 35(5):377-82. PubMed ID: 17885733
[TBL] [Abstract][Full Text] [Related]
55. Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia.
Gumbo T; Drusano GL; Liu W; Kulawy RW; Fregeau C; Hsu V; Louie A
Antimicrob Agents Chemother; 2007 Mar; 51(3):968-74. PubMed ID: 17194830
[TBL] [Abstract][Full Text] [Related]
56. [Cryptococcosis--a common fungal infection in immunosuppressed patient].
Botnaru V; Rusu D; Haidarlî I; Munteanu O; Corlateanu A
Pneumologia; 2014; 63(3):156, 159-63. PubMed ID: 25420290
[TBL] [Abstract][Full Text] [Related]
57. Micafungin: new drug. Severe candidiasis: a third echinocandin, with life-threatening hepatotoxicity.
Prescrire Int; 2009 Aug; 18(102):154. PubMed ID: 19743568
[No Abstract] [Full Text] [Related]
58. Pericardial effusion due to Cryptococcus neoformans in a patient with cystic fibrosis following lung transplantation.
Levy PY; Habib G; Reynaud-Gaubert M; Raoult D; Rolain JM
Int J Infect Dis; 2008 Jul; 12(4):452. PubMed ID: 18207443
[No Abstract] [Full Text] [Related]
59. Itraconazole therapy for cryptococcal meningitis and cryptococcosis.
Denning DW; Tucker RM; Hanson LH; Hamilton JR; Stevens DA
Arch Intern Med; 1989 Oct; 149(10):2301-8. PubMed ID: 2552949
[TBL] [Abstract][Full Text] [Related]
60. Micafungin for the treatment of invasive aspergillosis.
Enoch DA; Idris SF; Aliyu SH; Micallef C; Sule O; Karas JA
J Infect; 2014 Jun; 68(6):507-26. PubMed ID: 24480373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
